Global Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2024-2030
Page: 123
Published Date: 03 Mar 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Infectious Bursal Disease Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
This report studies the global Infectious Bursal Disease Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Infectious Bursal Disease Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infectious Bursal Disease Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Infectious Bursal Disease Vaccine total production and demand, 2019-2030, (K Units)
Global Infectious Bursal Disease Vaccine total production value, 2019-2030, (USD Million)
Global Infectious Bursal Disease Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Infectious Bursal Disease Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Infectious Bursal Disease Vaccine domestic production, consumption, key domestic manufacturers and share
Global Infectious Bursal Disease Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Infectious Bursal Disease Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Infectious Bursal Disease Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Infectious Bursal Disease Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd. and Ruipu Biopharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infectious Bursal Disease Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Infectious Bursal Disease Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Infectious Bursal Disease Vaccine Market, Segmentation by Type
Live
Inactivated
Global Infectious Bursal Disease Vaccine Market, Segmentation by Application
Veterinary Pharmacy
Online Sale
Others
Companies Profiled:
Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Key Questions Answered
1. How big is the global Infectious Bursal Disease Vaccine market?
2. What is the demand of the global Infectious Bursal Disease Vaccine market?
3. What is the year over year growth of the global Infectious Bursal Disease Vaccine market?
4. What is the production and production value of the global Infectious Bursal Disease Vaccine market?
5. Who are the key producers in the global Infectious Bursal Disease Vaccine market?
Table of Contents
1 Supply Summary
1.1 Infectious Bursal Disease Vaccine Introduction
1.2 World Infectious Bursal Disease Vaccine Supply & Forecast
1.2.1 World Infectious Bursal Disease Vaccine Production Value (2019 & 2023 & 2030)
1.2.2 World Infectious Bursal Disease Vaccine Production (2019-2030)
1.2.3 World Infectious Bursal Disease Vaccine Pricing Trends (2019-2030)
1.3 World Infectious Bursal Disease Vaccine Production by Region (Based on Production Site)
1.3.1 World Infectious Bursal Disease Vaccine Production Value by Region (2019-2030)
1.3.2 World Infectious Bursal Disease Vaccine Production by Region (2019-2030)
1.3.3 World Infectious Bursal Disease Vaccine Average Price by Region (2019-2030)
1.3.4 North America Infectious Bursal Disease Vaccine Production (2019-2030)
1.3.5 Europe Infectious Bursal Disease Vaccine Production (2019-2030)
1.3.6 China Infectious Bursal Disease Vaccine Production (2019-2030)
1.3.7 Japan Infectious Bursal Disease Vaccine Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Infectious Bursal Disease Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Infectious Bursal Disease Vaccine Major Market Trends
2.1 World Infectious Bursal Disease Vaccine Demand (2019-2030)
2.2 World Infectious Bursal Disease Vaccine Consumption by Region
2.2.1 World Infectious Bursal Disease Vaccine Consumption by Region (2019-2024)
2.2.2 World Infectious Bursal Disease Vaccine Consumption Forecast by Region (2025-2030)
2.3 United States Infectious Bursal Disease Vaccine Consumption (2019-2030)
2.4 China Infectious Bursal Disease Vaccine Consumption (2019-2030)
2.5 Europe Infectious Bursal Disease Vaccine Consumption (2019-2030)
2.6 Japan Infectious Bursal Disease Vaccine Consumption (2019-2030)
2.7 South Korea Infectious Bursal Disease Vaccine Consumption (2019-2030)
2.8 ASEAN Infectious Bursal Disease Vaccine Consumption (2019-2030)
2.9 India Infectious Bursal Disease Vaccine Consumption (2019-2030)
3.1 World Infectious Bursal Disease Vaccine Production Value by Manufacturer (2019-2024)
3.2 World Infectious Bursal Disease Vaccine Production by Manufacturer (2019-2024)
3.3 World Infectious Bursal Disease Vaccine Average Price by Manufacturer (2019-2024)
3.4 Infectious Bursal Disease Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Infectious Bursal Disease Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Infectious Bursal Disease Vaccine in 2023
3.5.3 Global Concentration Ratios (CR8) for Infectious Bursal Disease Vaccine in 2023
3.6 Infectious Bursal Disease Vaccine Market: Overall Company Footprint Analysis
3.6.1 Infectious Bursal Disease Vaccine Market: Region Footprint
3.6.2 Infectious Bursal Disease Vaccine Market: Company Product Type Footprint
3.6.3 Infectious Bursal Disease Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Infectious Bursal Disease Vaccine Production Value Comparison
4.1.1 United States VS China: Infectious Bursal Disease Vaccine Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Infectious Bursal Disease Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Infectious Bursal Disease Vaccine Production Comparison
4.2.1 United States VS China: Infectious Bursal Disease Vaccine Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Infectious Bursal Disease Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Infectious Bursal Disease Vaccine Consumption Comparison
4.3.1 United States VS China: Infectious Bursal Disease Vaccine Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Infectious Bursal Disease Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Infectious Bursal Disease Vaccine Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Infectious Bursal Disease Vaccine Production Value (2019-2024)
4.4.3 United States Based Manufacturers Infectious Bursal Disease Vaccine Production (2019-2024)
4.5 China Based Infectious Bursal Disease Vaccine Manufacturers and Market Share
4.5.1 China Based Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Infectious Bursal Disease Vaccine Production Value (2019-2024)
4.5.3 China Based Manufacturers Infectious Bursal Disease Vaccine Production (2019-2024)
4.6 Rest of World Based Infectious Bursal Disease Vaccine Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Infectious Bursal Disease Vaccine Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Infectious Bursal Disease Vaccine Production (2019-2024)
5.1 World Infectious Bursal Disease Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Live
5.2.2 Inactivated
5.3 Market Segment by Type
5.3.1 World Infectious Bursal Disease Vaccine Production by Type (2019-2030)
5.3.2 World Infectious Bursal Disease Vaccine Production Value by Type (2019-2030)
5.3.3 World Infectious Bursal Disease Vaccine Average Price by Type (2019-2030)
6.1 World Infectious Bursal Disease Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Veterinary Pharmacy
6.2.2 Online Sale
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Infectious Bursal Disease Vaccine Production by Application (2019-2030)
6.3.2 World Infectious Bursal Disease Vaccine Production Value by Application (2019-2030)
6.3.3 World Infectious Bursal Disease Vaccine Average Price by Application (2019-2030)
7.1 Zoetis
7.1.1 Zoetis Details
7.1.2 Zoetis Major Business
7.1.3 Zoetis Infectious Bursal Disease Vaccine Product and Services
7.1.4 Zoetis Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Zoetis Recent Developments/Updates
7.1.6 Zoetis Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Infectious Bursal Disease Vaccine Product and Services
7.2.4 Merck Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Elanco
7.3.1 Elanco Details
7.3.2 Elanco Major Business
7.3.3 Elanco Infectious Bursal Disease Vaccine Product and Services
7.3.4 Elanco Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Elanco Recent Developments/Updates
7.3.6 Elanco Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Details
7.4.2 Boehringer Ingelheim Major Business
7.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product and Services
7.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Boehringer Ingelheim Recent Developments/Updates
7.4.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.5 Ceva
7.5.1 Ceva Details
7.5.2 Ceva Major Business
7.5.3 Ceva Infectious Bursal Disease Vaccine Product and Services
7.5.4 Ceva Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Ceva Recent Developments/Updates
7.5.6 Ceva Competitive Strengths & Weaknesses
7.6 Qingdao Yibang Biological Engineering Co., Ltd.
7.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Details
7.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Major Business
7.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
7.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
7.6.6 Qingdao Yibang Biological Engineering Co., Ltd. Competitive Strengths & Weaknesses
7.7 Shandong Lvdu Biological Technology Co., Ltd.
7.7.1 Shandong Lvdu Biological Technology Co., Ltd. Details
7.7.2 Shandong Lvdu Biological Technology Co., Ltd. Major Business
7.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
7.7.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
7.7.6 Shandong Lvdu Biological Technology Co., Ltd. Competitive Strengths & Weaknesses
7.8 Plyco Bioengineering Co., Ltd.
7.8.1 Plyco Bioengineering Co., Ltd. Details
7.8.2 Plyco Bioengineering Co., Ltd. Major Business
7.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
7.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Plyco Bioengineering Co., Ltd. Recent Developments/Updates
7.8.6 Plyco Bioengineering Co., Ltd. Competitive Strengths & Weaknesses
7.9 Ruipu Biopharmaceutical Co., Ltd.
7.9.1 Ruipu Biopharmaceutical Co., Ltd. Details
7.9.2 Ruipu Biopharmaceutical Co., Ltd. Major Business
7.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
7.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.9.6 Ruipu Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
7.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Details
7.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Major Business
7.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
7.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
7.10.6 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Competitive Strengths & Weaknesses
8.1 Infectious Bursal Disease Vaccine Industry Chain
8.2 Infectious Bursal Disease Vaccine Upstream Analysis
8.2.1 Infectious Bursal Disease Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Infectious Bursal Disease Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Infectious Bursal Disease Vaccine Production Mode
8.6 Infectious Bursal Disease Vaccine Procurement Model
8.7 Infectious Bursal Disease Vaccine Industry Sales Model and Sales Channels
8.7.1 Infectious Bursal Disease Vaccine Sales Model
8.7.2 Infectious Bursal Disease Vaccine Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Infectious Bursal Disease Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Infectious Bursal Disease Vaccine Production Value by Region (2019-2024) & (USD Million)
Table 3. World Infectious Bursal Disease Vaccine Production Value by Region (2025-2030) & (USD Million)
Table 4. World Infectious Bursal Disease Vaccine Production Value Market Share by Region (2019-2024)
Table 5. World Infectious Bursal Disease Vaccine Production Value Market Share by Region (2025-2030)
Table 6. World Infectious Bursal Disease Vaccine Production by Region (2019-2024) & (K Units)
Table 7. World Infectious Bursal Disease Vaccine Production by Region (2025-2030) & (K Units)
Table 8. World Infectious Bursal Disease Vaccine Production Market Share by Region (2019-2024)
Table 9. World Infectious Bursal Disease Vaccine Production Market Share by Region (2025-2030)
Table 10. World Infectious Bursal Disease Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Infectious Bursal Disease Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Infectious Bursal Disease Vaccine Major Market Trends
Table 13. World Infectious Bursal Disease Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Infectious Bursal Disease Vaccine Consumption by Region (2019-2024) & (K Units)
Table 15. World Infectious Bursal Disease Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Infectious Bursal Disease Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Infectious Bursal Disease Vaccine Producers in 2023
Table 18. World Infectious Bursal Disease Vaccine Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Infectious Bursal Disease Vaccine Producers in 2023
Table 20. World Infectious Bursal Disease Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Infectious Bursal Disease Vaccine Company Evaluation Quadrant
Table 22. World Infectious Bursal Disease Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Infectious Bursal Disease Vaccine Production Site of Key Manufacturer
Table 24. Infectious Bursal Disease Vaccine Market: Company Product Type Footprint
Table 25. Infectious Bursal Disease Vaccine Market: Company Product Application Footprint
Table 26. Infectious Bursal Disease Vaccine Competitive Factors
Table 27. Infectious Bursal Disease Vaccine New Entrant and Capacity Expansion Plans
Table 28. Infectious Bursal Disease Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Infectious Bursal Disease Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Infectious Bursal Disease Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Infectious Bursal Disease Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Infectious Bursal Disease Vaccine Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Infectious Bursal Disease Vaccine Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Infectious Bursal Disease Vaccine Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Infectious Bursal Disease Vaccine Production Market Share (2019-2024)
Table 37. China Based Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Infectious Bursal Disease Vaccine Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Infectious Bursal Disease Vaccine Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Infectious Bursal Disease Vaccine Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Infectious Bursal Disease Vaccine Production Market Share (2019-2024)
Table 42. Rest of World Based Infectious Bursal Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Infectious Bursal Disease Vaccine Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Infectious Bursal Disease Vaccine Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Infectious Bursal Disease Vaccine Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Infectious Bursal Disease Vaccine Production Market Share (2019-2024)
Table 47. World Infectious Bursal Disease Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Infectious Bursal Disease Vaccine Production by Type (2019-2024) & (K Units)
Table 49. World Infectious Bursal Disease Vaccine Production by Type (2025-2030) & (K Units)
Table 50. World Infectious Bursal Disease Vaccine Production Value by Type (2019-2024) & (USD Million)
Table 51. World Infectious Bursal Disease Vaccine Production Value by Type (2025-2030) & (USD Million)
Table 52. World Infectious Bursal Disease Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Infectious Bursal Disease Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Infectious Bursal Disease Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Infectious Bursal Disease Vaccine Production by Application (2019-2024) & (K Units)
Table 56. World Infectious Bursal Disease Vaccine Production by Application (2025-2030) & (K Units)
Table 57. World Infectious Bursal Disease Vaccine Production Value by Application (2019-2024) & (USD Million)
Table 58. World Infectious Bursal Disease Vaccine Production Value by Application (2025-2030) & (USD Million)
Table 59. World Infectious Bursal Disease Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Infectious Bursal Disease Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Zoetis Basic Information, Manufacturing Base and Competitors
Table 62. Zoetis Major Business
Table 63. Zoetis Infectious Bursal Disease Vaccine Product and Services
Table 64. Zoetis Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Zoetis Recent Developments/Updates
Table 66. Zoetis Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Infectious Bursal Disease Vaccine Product and Services
Table 70. Merck Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. Elanco Basic Information, Manufacturing Base and Competitors
Table 74. Elanco Major Business
Table 75. Elanco Infectious Bursal Disease Vaccine Product and Services
Table 76. Elanco Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Elanco Recent Developments/Updates
Table 78. Elanco Competitive Strengths & Weaknesses
Table 79. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim Major Business
Table 81. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product and Services
Table 82. Boehringer Ingelheim Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Boehringer Ingelheim Recent Developments/Updates
Table 84. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 85. Ceva Basic Information, Manufacturing Base and Competitors
Table 86. Ceva Major Business
Table 87. Ceva Infectious Bursal Disease Vaccine Product and Services
Table 88. Ceva Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Ceva Recent Developments/Updates
Table 90. Ceva Competitive Strengths & Weaknesses
Table 91. Qingdao Yibang Biological Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. Qingdao Yibang Biological Engineering Co., Ltd. Major Business
Table 93. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
Table 94. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
Table 96. Qingdao Yibang Biological Engineering Co., Ltd. Competitive Strengths & Weaknesses
Table 97. Shandong Lvdu Biological Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Shandong Lvdu Biological Technology Co., Ltd. Major Business
Table 99. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
Table 100. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
Table 102. Shandong Lvdu Biological Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 103. Plyco Bioengineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Plyco Bioengineering Co., Ltd. Major Business
Table 105. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
Table 106. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Plyco Bioengineering Co., Ltd. Recent Developments/Updates
Table 108. Plyco Bioengineering Co., Ltd. Competitive Strengths & Weaknesses
Table 109. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 110. Ruipu Biopharmaceutical Co., Ltd. Major Business
Table 111. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
Table 112. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 114. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 115. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Major Business
Table 116. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
Table 117. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Infectious Bursal Disease Vaccine Upstream (Raw Materials)
Table 119. Infectious Bursal Disease Vaccine Typical Customers
Table 120. Infectious Bursal Disease Vaccine Typical Distributors
List of Figure
Figure 1. Infectious Bursal Disease Vaccine Picture
Figure 2. World Infectious Bursal Disease Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Infectious Bursal Disease Vaccine Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Infectious Bursal Disease Vaccine Production (2019-2030) & (K Units)
Figure 5. World Infectious Bursal Disease Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 6. World Infectious Bursal Disease Vaccine Production Value Market Share by Region (2019-2030)
Figure 7. World Infectious Bursal Disease Vaccine Production Market Share by Region (2019-2030)
Figure 8. North America Infectious Bursal Disease Vaccine Production (2019-2030) & (K Units)
Figure 9. Europe Infectious Bursal Disease Vaccine Production (2019-2030) & (K Units)
Figure 10. China Infectious Bursal Disease Vaccine Production (2019-2030) & (K Units)
Figure 11. Japan Infectious Bursal Disease Vaccine Production (2019-2030) & (K Units)
Figure 12. Infectious Bursal Disease Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Infectious Bursal Disease Vaccine Consumption (2019-2030) & (K Units)
Figure 15. World Infectious Bursal Disease Vaccine Consumption Market Share by Region (2019-2030)
Figure 16. United States Infectious Bursal Disease Vaccine Consumption (2019-2030) & (K Units)
Figure 17. China Infectious Bursal Disease Vaccine Consumption (2019-2030) & (K Units)
Figure 18. Europe Infectious Bursal Disease Vaccine Consumption (2019-2030) & (K Units)
Figure 19. Japan Infectious Bursal Disease Vaccine Consumption (2019-2030) & (K Units)
Figure 20. South Korea Infectious Bursal Disease Vaccine Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Infectious Bursal Disease Vaccine Consumption (2019-2030) & (K Units)
Figure 22. India Infectious Bursal Disease Vaccine Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Infectious Bursal Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Infectious Bursal Disease Vaccine Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Infectious Bursal Disease Vaccine Markets in 2023
Figure 26. United States VS China: Infectious Bursal Disease Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Infectious Bursal Disease Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Infectious Bursal Disease Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Infectious Bursal Disease Vaccine Production Market Share 2023
Figure 30. China Based Manufacturers Infectious Bursal Disease Vaccine Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Infectious Bursal Disease Vaccine Production Market Share 2023
Figure 32. World Infectious Bursal Disease Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Infectious Bursal Disease Vaccine Production Value Market Share by Type in 2023
Figure 34. Live
Figure 35. Inactivated
Figure 36. World Infectious Bursal Disease Vaccine Production Market Share by Type (2019-2030)
Figure 37. World Infectious Bursal Disease Vaccine Production Value Market Share by Type (2019-2030)
Figure 38. World Infectious Bursal Disease Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Infectious Bursal Disease Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Infectious Bursal Disease Vaccine Production Value Market Share by Application in 2023
Figure 41. Veterinary Pharmacy
Figure 42. Online Sale
Figure 43. Others
Figure 44. World Infectious Bursal Disease Vaccine Production Market Share by Application (2019-2030)
Figure 45. World Infectious Bursal Disease Vaccine Production Value Market Share by Application (2019-2030)
Figure 46. World Infectious Bursal Disease Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Infectious Bursal Disease Vaccine Industry Chain
Figure 48. Infectious Bursal Disease Vaccine Procurement Model
Figure 49. Infectious Bursal Disease Vaccine Sales Model
Figure 50. Infectious Bursal Disease Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Zoetis Merck Elanco Boehringer Ingelheim Ceva Qingdao Yibang Biological Engineering Co., Ltd. Shandong Lvdu Biological Technology Co., Ltd. Plyco Bioengineering Co., Ltd. Ruipu Biopharmaceutical Co., Ltd. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Related Reports
10 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
